• Home
  • Biopharma AI
  • How Xsolis’ AI-Driven Dragonfly Clinched the 2025 MedTech’s ‘Clinical Efficiency Innovation Award’? Targets the $1 Trillion U.S. Healthcare Waste Crisis Clinical Efficiency Innovation Award

How Xsolis’ AI-Driven Dragonfly Clinched the 2025 MedTech’s ‘Clinical Efficiency Innovation Award’? Targets the $1 Trillion U.S. Healthcare Waste Crisis Clinical Efficiency Innovation Award

Key Highlights

  • Xsolis’ Dragonfly awarded 2025 MedTech Breakthrough “Clinical Efficiency Innovation Award” for transforming payer-provider collaboration using AI
  • Dragonfly leverages real-time predictive analytics to optimize care levels, reduce waste, and streamline medical necessity decisions
  • Generative AI integration positions Dragonfly as a next-gen digital co-pilot for nurses, providers, and payers across the U.S.

Xsolis Sets New Standard in AI-Powered Clinical Efficiency
Tennessee-based AI tech firm Xsolis has won top honors at the 2025 MedTech Breakthrough Awards for its Dragonfly platform, recognized as a market leader in solving one of healthcare’s most expensive and complex challenges: administrative waste. Dragonfly uses predictive analytics to assign objective medical necessity scores and suggest care levels in real time, aligning health plans and providers before conflict arises.

Dragonfly: Turning Friction into Function Between Payers and Providers
Administrative overhead in U.S. healthcare approaches $1 trillion annually—primarily due to inefficient workflows between insurers and providers. Dragonfly addresses this by integrating directly into hospital systems, automatically generating aligned medical necessity decisions. The platform removes guesswork and redundancy while enabling shared data access across previously siloed stakeholders.

Generative + Predictive AI: A Digital Co-Pilot for Clinicians
Launched in late 2024, Dragonfly’s latest upgrade adds generative AI to its predictive core. Nurses and care managers benefit from decision support that eliminates repetitive tasks, reduces documentation burden, and boosts accuracy in level-of-care forecasting. It enables smarter, more collaborative care transitions—improving patient outcomes while protecting clinicians’ time.

Market Impact: Global Recognition for U.S. Innovation
The 2025 MedTech Breakthrough Awards received record-breaking entries from over 18 countries. Xsolis’ win validates its growing influence as an AI innovator redefining value-based care infrastructure. With payer-provider friction identified as the top barrier in a 2024 HFMA survey of revenue leaders, Dragonfly is positioned as a must-have solution for sustainable digital healthcare delivery.

About Xsolis
Xsolis is a Franklin, Tennessee-based AI healthcare technology company helping providers and payers reduce friction, align on medical necessity, and eliminate administrative waste through predictive analytics. Its flagship solution, Dragonfly®, offers a real-time, interoperable platform that enables smarter utilization decisions and better patient care outcomes.

About MedTech Breakthrough
MedTech Breakthrough is part of Tech Breakthrough, a leading market recognition platform honoring excellence in digital health and medical technologies. Its annual awards spotlight disruptive innovators across categories such as patient engagement, AI, cybersecurity, and clinical operations.

Releated Posts

Are AI Healthcare Tools Raising Ethical and Access Concerns?

January 26, 2026 | AI in Healthcare | Ethics, Equity & Policy Recent commentary in leading medical and…

ByByAnuja Singh Jan 26, 2026

Is “ChatGPT for Doctors” Driving OpenEvidence’s $12 B Valuation Surge?

January 26, 2026 | AI in Healthcare | Strategic Investment & Market Expansion OpenEvidence, the AI platform often…

ByByAnuja Singh Jan 26, 2026

Will Johnson & Johnson’s 2025 Earnings Reinforce Confidence in Its Pharma-Led Growth Engine?

Late January 2026 | Full-Year 2025 Earnings Preview | Diversified Pharma Outlook Johnson & Johnson (J&J) is set…

ByByAnuja Singh Jan 26, 2026

Can AI-Driven Chemistry Partnerships Like Merck–ChemLex Accelerate Drug Discovery?

23 January 2026 Executive Summary Merck has signed a Memorandum of Understanding (MoU) with ChemLex, initiating a strategic…

ByByAnuja Singh Jan 24, 2026
Scroll to Top